ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, featuring promising developments throughout several healthcare and industrial apps. With its structural similarity to By natural means derived human serum albumin, OsrHSA supplies a safer, much more reputable alternate for therapeutic use